HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Panteleon, A. E. Articles by Rebrin, K. Search for Related Content PubMed PubMed Citation Articles by Panteleon, A. E. Articles by Rebrin, K. Social Bookmarking                What's this?

Evaluation of the Effect of Gain on the Meal Response of an Automated Closed-Loop Insulin Delivery System

From Medtronic MiniMed, Northridge, California

Address correspondence and reprint requests to Garry Steil, PhD, Medtronic MiniMed, 18000 Devonshire Rd., Northridge, CA 91325. E-mail: garry.steil{at}medtronic.com

Abbreviations: AUC, area under the curve; TDD, total daily dose

A continuous closed-loop insulin delivery system using subcutaneous insulin delivery was evaluated in eight diabetic canines. Continuous glucose profiles were obtained by extrapolation of blood glucose measurements. Insulin delivery rate was calculated, using a model of ß-cell insulin secretion, and delivered with a Medtronic MiniMed subcutaneous infusion pump. The model acts like a classic proportional-integral-derivative controller, delivering insulin in proportion to glucose above target, history of past glucose values, and glucose rate of change. For each dog, a proportional gain was set relative to the open-loop total daily dose (TDD) of insulin. Additional gains based on 0.5 x TDD and 1.5 x TDD were also evaluated (gain dose response). Control was initiated 4 h before the meal with a target of 6.7 mmol/l. At the time of the meal, glucose was similar for all three gains (6.0 ± 0.3, 5.2 ± 0.3, and 4.9 ± 0.5 mmol/l for 0.5 x TDD, TDD, and 1.5 x TDD, respectively; P > 0.05) with near-target values restored at the end of experiments (8.2 ± 0.9, 6.0 ± 0.6, and 6.0 ± 0.5, respectively). The peak postprandial glucose level decreased significantly with increasing gain (12.1 ± 0.6, 9.6 ± 1.0, and 8.5 ± 0.6 mmol/l, respectively; P < 0.05). The data demonstrate that closed-loop insulin delivery using the subcutaneous site can provide stable glycemic control within a range of gain.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. M. Steil, K. Rebrin, C. Darwin, F. Hariri, and M. F. Saad Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes Diabetes, December 1, 2006; 55(12): 3344 - 3350. [Abstract] [Full Text] [PDF]